Equity and Net Income (Loss) per Share - Anti-dilutive securities (Details) - shares	3 Months Ended
Mar. 31, 2023	Mar. 31, 2022
Equity and Net Income (Loss) per Share
Anti-dilutive securities	4,627,713	3,693,288
Warrants to purchase common stock
Equity and Net Income (Loss) per Share
Anti-dilutive securities	92,703	92,703
Options to purchase common stock
Equity and Net Income (Loss) per Share
Anti-dilutive securities	2,626,584	2,868,305
Performance stock units
Equity and Net Income (Loss) per Share
Anti-dilutive securities	53,794
Restricted stock units
Equity and Net Income (Loss) per Share
Anti-dilutive securities	1,854,632	732,280

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration